PlexusDx emphasizes the importance of biomarker and genetic context in personalizing any medication strategy, including when metformin and GLP-1 therapies are being evaluated together
Additionally, overexpression of the inosine-5-monophosphate dehydrogenase (IMPDH) gene increased metabolic flux through the guanine pathway and ultimately enhanced riboflavin production by 40% compared to the wild-type A
While definitive causal reduction in cancer risk with GLP-1 therapies is not established, the cardiovascular and metabolic benefits of significant weight loss may outweigh theoretical cancer concerns for many patients
In 2025, it was reported that around 12 to 14 percent of the American population were using GLP-1 drugs for weight loss purposes, and Trey Luker-Stewart was one of them
This quick onset reflects how rapidly GLP-1 and GIP receptors in your brain's satiety centers respond to the medication
Updated February 21, 2018